Yicheng Wen

President and Managing Director 

Yicheng Wen is an accomplished leader in the medical industry and a savvy investor with extensive experience across various roles at Thalys Medical Group (SHA: 603716), a leading healthcare corporation based in Wuhan, China. With a board membership since 2017, Yicheng has played a pivotal role in the company's strategic growth, leveraging his deep expertise in business development, clinical diagnostics, medical technology investments, and operational management.

Yicheng’s career has been defined by his visionary approach and ability to drive significant advancements in the healthcare sector. His work spans a diverse range of functions, from spearheading business development initiatives in Clinical In-Vitro Diagnostics (IVD) to managing investments in medical technology companies. As General Manager of Investments, he successfully secured strategic funding, including a 200 million RMB investment from Hangzhou Investment Group, fueling Thalys' expansion and growth. His strategic vision, market insights, and negotiation expertise have been instrumental in securing substantial investments and advancing the company’s leadership position.

In addition to his work at Thalys, Yicheng has made a mark as an investor, particularly in the Canadian startup ecosystem. He has successfully identified and invested in high-potential companies within the technology, traffic control, and battery management sectors. His investment strategy reflects a keen understanding of emerging trends and a commitment to supporting innovative ventures that shape the future of these industries.

Yicheng's leadership skills were further demonstrated in his remarkable turnaround of Site 20/20 Inc., where he implemented a roll-up strategy that transformed the company from a small three-member operation into a thriving business with 480 employees and a projected revenue of 60 million USD in 2024. His ability to lead through change and scale operations has made him a sought-after executive with a proven track record of delivering results.

Throughout his tenure at Thalys Medical Group, Yicheng has held various senior roles, including General Manager of SPD Operations and General Manager of Investment and Legal. His expertise in both operational leadership and strategic investment has been critical in driving the company's success across multiple sectors. His recent role as Assistant Director to the Chairman further demonstrated his ability to collaborate with top management and execute the company’s long-term vision.

With a passion for innovation and a commitment to excellence, Yicheng continues to lead with a strategic mindset and a focus on making a positive impact in the medical and technology sectors.